Menu Close
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
    • The Flipside
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech
An Official Publication of
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
    • The Flipside
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech

COVID-19

  • 1
    News

    HM administrators plan for 2021 and beyond

    August 13, 2021

    “If there was ever doubt that the hospitalists are the beating heart of the hospital, this doubt is now gone,” said Elda Dede, FHM.

  • 1
    News

    FDA authorizes booster shot for immunocompromised Americans

    August 13, 2021

    Those eligible for a third dose include solid organ transplant recipients, those undergoing cancer treatments, and people with autoimmune diseases that suppress their immune systems.

  • 1
    News

    Hospitals struggle to find nurses, beds, even oxygen as Delta surges

    August 12, 2021

    “We have a vaccine, which is the key to ending this pandemic and people just refuse to take it, and so I think we’re very frustrated.”

  • 1
    News

    FDA may okay COVID booster for vulnerable adults before weekend: Media

    August 12, 2021

    Between one-third and one-half of immunocompromised patients who didn’t develop detectable levels of virus-fighting antibodies after two doses of a COVID vaccine will respond to a third dose.

  • News

    COVID-19 mitigation measures led to shifts in typical annual respiratory virus patterns

    August 11, 2021

    “Clinicians should be aware of increases in some respiratory virus activity and remain vigilant for off-season increases.”

  • News

    Myocarditis in adolescents after COVID-19 vaccine typically mild

    August 11, 2021

    “Despite the risks of myocarditis associated with vaccination, the benefits of vaccination likely outweigh risks in children and adolescents.”

  • 1
    News

    Surge of new child COVID cases continues for 6th consecutive week

    August 10, 2021

    Upward trend in vaccine initiation is now in its 4th week among 12- to 15-year-olds.

  • 1
    Opinion

    Microlearning during the pandemic

    August 9, 2021

    Microlearning occurs when clinicians turn to their smartphones or tablets in order to discover something, answer a question, or complete a task.

  • 1
    News

    Fauci says ‘unprecedented’ conditions could influence COVID vaccine approval for kids

    August 6, 2021

    “If I were a [non-COVID] virus looking for a niche, I would be really confused,” Dr. Fauci told pediatric hospitalists.

  • 1
    News

    Injectable monoclonal antibodies prevent COVID-19 in trial

    August 6, 2021

    The cocktail of casirivimab and imdevimab reduced the relative risk of infection by 72% in patients at high risk of infection.

Previous1 … 15 16 17 18 19 … 131Next
  • About The Hospitalist
  • Contact Us
  • The Editors
  • Editorial Board
  • Authors
  • Publishing Opportunities
  • Subscribe
  • Advertise
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies.
    ISSN 1553-085X
  • Privacy Policy
  • Terms and Conditions
  • SHM’s DE&I Statement
  • Cookie Preferences